PRNewsWire
09 Jul 2026, 19:32 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ADMA Biologics is facing a securities fraud class action lawsuit alleging the use of channel stuffing to artificially inflate revenue. — Allegations of revenue manipulation (channel stuffing) strike at the core of financial integrity and typically lead to significant valuation corrections.
-0.70The lawsuit alleges that ADMA Biologics engaged in undisclosed related party transactions and lacked adequate internal controls. — Failure in internal controls and hidden related-party deals suggest systemic governance risks and potential for further financial irregularities.
-0.50The Law Offices of Frank R. Cruz is seeking a lead plaintiff for the class action with a deadline of August 10, 2026. — The procedural step of seeking a lead plaintiff confirms the litigation is moving forward, though it is a standard legal development.
-0.10Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company is the subject of a securities fraud class action lawsuit regarding investor losses.
The company is mentioned as being subject to a securities fraud class action lawsuit.
The company is facing a securities fraud class action lawsuit alleging channel stuffing and lack of internal controls.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
2h ago
